Back to discover
Drug

Ginsenosides

Research stage
Emerging research

Also known as Ginseng root-neutral saponins, Neutral saponins of panax ginseng root, Ginsenoside.

RxNorm25755UNII3K198YD54P
2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Ginsenosides
Aliases & brands
Ginseng root-neutral saponinsNeutral saponins of panax ginseng rootGinsenoside
RxNorm CUI
25755
UNII
3K198YD54P

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes6
Gastrointestinal Microbiome2Ginsenosides2Panax2Atherosclerosis1Homeostasis1Mice, Knockout1
Journals, researchers & institutions
Top journals
  • British journal of pharmacology1
  • Frontiers in immunology1
Leading researchers
  • Cao L1
  • Che Y1
  • Ding C1
  • Hao H1
  • Hong Y1
  • Jiang A1
  • Wang G1
  • Wang Y1
Leading institutions
free-text, unnormalised
  • Jiangsu Key Laboratory of Molecular Medicine1
  • School of Pharmacy1
  • State Key Laboratory of Natural Medicines1
  • The Second Hospital of Jilin University1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Plant Extracts

Studied across the same disease area as Ginsenosides in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature